Showing results (1061-1070 of 1,133) with videos related to
Sort By:
Pageof 114
International Journal of Cancer|February 27, 2023
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trialsMelissa M de Meza, Willeke A M Blokx, Han J Bonenkamp, et al.Cancers|October 23, 2021
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The NetherlandsJesper van Breeschoten, Alfonsus J M van den Eertwegh, Liesbeth C de Wreede, et al.Cancers|August 10, 2024
Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma PatientsDaan Jan Willem Rauwerdink, Olivier van Not, Melissa de Meza, et al.JAMA Network Open|August 14, 2024
Long-Term Survival in Patients With Advanced MelanomaOlivier J van Not, Alfons J M van den Eertwegh, Hilde Jalving, et al.Melanoma Research|December 22, 2020
Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastasesRawa K Ismail, Nienke O Sikkes, Michel W J M Wouters, et al.European Journal of Cancer (Oxford, England : 1990)|August 9, 2020
Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands - A nationwide population-based studyMichiel C T van Zeijl, Florine L Boer, Mariëtte I E van Poelgeest, et al.European Journal of Cancer (Oxford, England : 1990)|April 6, 2023
Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignanciesOlivier J Van Not, Alfons J M van den Eertwegh, John B Haanen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 27, 2023
Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the NetherlandsMichiel C T van Zeijl, Jesper van Breeschoten, Liesbeth C de Wreede, et al.Cancers|December 11, 2019
Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?Maartje G Schouwenburg, Karijn P M Suijkerbuijk, Rutger H T Koornstra, et al.Annals of Internal Medicine|February 15, 2021
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort StudyMonique K van der Kooij, Karijn P M Suijkerbuijk, Maureen J B Aarts, et al.Pageof 114